Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
Department of Internal Medicine, Ono Municipal Hospital, Ono, Hyogo, Japan.
PLoS One. 2022 Oct 12;17(10):e0274685. doi: 10.1371/journal.pone.0274685. eCollection 2022.
Despite the poor prognosis for nursing home acquired pneumonia (NHAP), a useful prognostic factor is lacking. We evaluated protein C (PC) activity as a predictor of in-hospital death in patients with NHAP and community-acquired pneumonia (CAP).
This prospective, observational study included all patients hospitalized with pneumonia between July 2007 and December 2012 in a single hospital. We measured PC activity at admission and investigated whether it was different between survivors and non-survivors. We also examined whether PC activity < 55% was a predictor for in-hospital death of pneumonia by logistic regression analysis with CURB-65 items (confusion, blood urea >20 mg/dL, respiratory rate >30/min, and blood pressure <90/60 mmHg, age >65). When it was a useful prognostic factor for pneumonia, we combined PC activity with the existing prognostic scores, the pneumonia severity index (PSI) and CURB-65, and analyzed its additional effect by comparing the areas under the receiver operating characteristic curves (AUCs) of the modified and original scores.
Participants comprised 75 NHAP and 315 CAP patients. PC activity was lower among non-survivors than among survivors in NHAP and all-pneumonia (CAP+NHAP). PC activity <55% was a useful prognostic predictor for NHAP (Odds ratio 7.39 (95% CI; 1.59-34.38), and when PSI or CURB-65 was combined with PC activity, the AUC improved (from 0.712 to 0.820 for PSI, and 0.657 to 0.734 for CURB-65).
PC activity was useful for predicting in-hospital death of pneumonia, especially in NHAP, and became more useful when combined with the PSI or CURB-65.
尽管养老院获得性肺炎(NHAP)的预后较差,但缺乏有用的预后因素。我们评估了蛋白 C(PC)活性作为 NHAP 和社区获得性肺炎(CAP)患者住院期间死亡的预测因子。
本前瞻性观察性研究纳入了 2007 年 7 月至 2012 年 12 月期间在一家医院住院的所有肺炎患者。我们在入院时测量了 PC 活性,并研究了幸存者和非幸存者之间是否存在差异。我们还通过逻辑回归分析 CURB-65 项目(意识障碍、血尿素 >20mg/dL、呼吸频率 >30/min、血压 <90/60mmHg、年龄 >65 岁)来检查 PC 活性 <55% 是否是肺炎院内死亡的预测因子。当 PC 活性是肺炎的有用预后因素时,我们将其与现有的预后评分,肺炎严重指数(PSI)和 CURB-65 相结合,并通过比较修改后的和原始评分的受试者工作特征曲线(ROC)下面积(AUC)来分析其附加效果。
参与者包括 75 例 NHAP 和 315 例 CAP 患者。在 NHAP 和所有肺炎(CAP+NHAP)中,非幸存者的 PC 活性低于幸存者。PC 活性 <55% 是 NHAP 的有用预后预测因子(优势比 7.39(95%CI;1.59-34.38),当 PSI 或 CURB-65 与 PC 活性相结合时,AUC 提高(PSI 从 0.712 提高到 0.820,CURB-65 从 0.657 提高到 0.734)。
PC 活性可用于预测肺炎的院内死亡,尤其是在 NHAP 中,当与 PSI 或 CURB-65 结合使用时,其效果更为显著。